Local angel investors inject $287,000 to help medical device startup grow, shortly prior to receiving news of FDA clearance
FAIRWAY, Kan. – (February 20, 2017) – The Mid-America Angels investment network (MAA) announced a $287,000 investment in Voxello, an Iowa-based medical device company. The company’s primary product, called the noddleTM, is a pioneering solution that detects voluntary gestures in hospitalized patients who would otherwise be unable to communicate. Today, the company also announced the U.S. Food and Drug Administration (FDA) 510(k) clearance of the noddleTM .
This post originally appeared on Silicon Prairie News.
I often get asked about the role of a board of directors by both entrepreneurs and angels. I believe good boards can significantly and positively impact the growth of an early stage company.
The responsibility for that growth falls not just on the CEO and management team but the board as well. In addition, the board ensures accountability and transparency and helps establish appropriate procedures, set milestones and assess performance among other things. Read more
It’s that time of year–the time when entrepreneurs and supporters from across the Silicon Prairie gather to crown our greatest innovators and brightest stars.
This year, the Mid-America Angels investment network is honored to be one of five groups nominated for the Silicon Prairie News “Investor of the Year” award. We’ve been a mainstay capital provider and leader of many Silicon Prairie seed and Series A rounds since 2006. In less than ten years, MAA members have invested over $15 million in regional startups including EyeVerify, Aratana Therapeutics, Bulu Box, Rawxies and Zave and Rhythm Engineering. Read more
Lenexa, KS and Washington, D.C. – (March 28, 2014) – Mid-America Angels (MAA) is pleased to announce EyeVerify, a portfolio company since 2012, has received the 2014 Luis Villalobos Award, presented by the Angel Capital Association (ACA). The winner was announced at an awards dinner during the national ACA Summit in Washington, DC on Thursday, March 27th. Read more